{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:26:32Z","timestamp":1780655192558,"version":"3.54.1"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:p>This article reports the first documented case of successful dual therapy with upadacitinib (JAK inhibitor) and mirikizumab (anti-IL-23) for multi-refractory ulcerative proctitis, demonstrating clinical remission, biomarker normalization, and endoscopic improvement after failure of conventional therapies.<\/jats:p>","DOI":"10.1093\/ibd\/izaf113","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T19:26:37Z","timestamp":1746041197000},"page":"3470-3471","source":"Crossref","is-referenced-by-count":2,"title":["First Documented Case of Successful Dual Therapy With Upadacitinib and Mirikizumab for Multi-Refractory Ulcerative Proctitis"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6159-3447","authenticated-orcid":false,"given":"Daniel","family":"Robles de la Osa","sequence":"first","affiliation":[{"name":"Gastroenterology Department, University Care Complex of Palencia , Palencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia Mileva","family":"Semrik","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, University Clinic Reina Fabiola , C\u00f3rdoba ,","place":["Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5825-1377","authenticated-orcid":false,"given":"Alejandro","family":"M\u00ednguez Sabater","sequence":"additional","affiliation":[{"name":"IBD Unit, Gastroenterology Department, La Fe University and Polytechnic Hospital , Valencia ,","place":["Spain"]},{"name":"La Fe Health Research Institute (IIS La Fe) , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6619-1511","authenticated-orcid":false,"given":"Pilar","family":"Nos","sequence":"additional","affiliation":[{"name":"IBD Unit, Gastroenterology Department, La Fe University and Polytechnic Hospital , Valencia ,","place":["Spain"]},{"name":"La Fe Health Research Institute (IIS La Fe) , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"6","key":"2025120914514407700_CIT0001","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/14712598.2024.2369189","article-title":"Management of proctitis in ulcerative colitis and the place of biological therapies","volume":"24","author":"Deo","year":"2024","journal-title":"Expert Opin Biol Ther."},{"issue":"7","key":"2025120914514407700_CIT0002","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjx009","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. part 2: current management","volume":"11","author":"Harbord","year":"2017","journal-title":"J Crohns Colitis."},{"issue":"5","key":"2025120914514407700_CIT0003","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.18133","article-title":"Need for therapeutic escalation in patients with refractory ulcerative proctitis: results from the PROCU study of the ENEIDA registry","volume":"60","author":"Ferreiro-Iglesias","year":"2024","journal-title":"Aliment Pharmacol Ther."},{"issue":"3","key":"2025120914514407700_CIT0004","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.cgh.2019.05.060","article-title":"Efficacy of tumor necrosis factor antagonist treatment in patients with refractory ulcerative proctitis","volume":"18","author":"Pineton de Chambrun","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2025120914514407700_CIT0005","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.cgh.2023.06.023","article-title":"Outcome of biological therapies and small molecules in ulcerative proctitis: a Belgian multicenter cohort study","volume":"22","author":"Lemmens","year":"2024","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"3","key":"2025120914514407700_CIT0006","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/ecco-jcc\/jjad169","article-title":"Tofacitinib for patients with anti-TNF refractory ulcerative proctitis: a multicentre cohort study from the GETAID","volume":"18","author":"Uzzan","year":"2024","journal-title":"J Crohns Colitis."},{"issue":"3","key":"2025120914514407700_CIT0007","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/apt.18406","article-title":"Comparative efficacy and safety of three janus kinase inhibitors in ulcerative colitis: a real-world multicentre study in Japan","volume":"61","author":"Akiyama","year":"2024","journal-title":"Aliment Pharmacol Ther."},{"issue":"12","key":"2025120914514407700_CIT0008","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1093\/ibd\/izae024","article-title":"Two-year efficacy and safety of mirikizumab following 104 weeks of continuous treatment for ulcerative colitis: results from the LUCENT-3 open-label extension study","volume":"30","author":"Sands","year":"2024","journal-title":"Inflamm Bowel Dis."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izaf113\/63328642\/izaf113.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/12\/3470\/63328642\/izaf113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/12\/3470\/63328642\/izaf113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T19:51:51Z","timestamp":1765309911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/12\/3470\/8145490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":8,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,5,24]]},"published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izaf113","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,5,24]]}}}